Monthly News Roundup - November 2022

FDA Approves Hemgenix, a Historic, One-Time Gene Therapy for Hemophilia B In November, the U.S. Food and Drug Administration (FDA) approved CSL Behring’s Hemgenix (etranacogene dezaparvovec-drlb), an adeno-associated virus vector-based gene...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news